Memphis profit increases by April
Updated 5/30/2021 12:18:37 PM
ArabFinance: Memphis Pharmaceutical posted a profit of EGP 34.18 million by the end of April 2021, 558% higher when compared to EGP 5.2 million in the same period of 2020, according to the company’s statement to the Egyptian Exchange on May 30th.
The company’s revenues leveled up to EGP 453.94 million during the four-month ended in April, compared to EGP 431.02 million in the same period a year ago.
The company’s unaudited financials showed that the company posted a net profit of EGP 25.373 million in quarter one (Q1) of 2021.
Memphis is one of the oldest pharmaceutical and chemical companies in the Middle East and has been in the market since 1940.
